EMERGENT HEALTH CORP |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0015 USD | +7.14% |
|
-28.57% | +114.29% |
| 2023 | Emergent Health Corp. Appoints Charlie McMenamin to Its Board of Director | CI |
| 2023 | Emergent Health Corp agreed to acquire Nanosthetic Corp. | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 |
|---|---|---|
| Capitalization 1 | 2.981 | 3.254 |
| Enterprise Value (EV) 1 | 2.812 | 3.334 |
| P/E ratio | -52.2 x | -11.3 x |
| Yield | - | - |
| Capitalization / Revenue | 17.8 x | 27.2 x |
| EV / Revenue | 16.8 x | 27.9 x |
| EV / EBITDA | -50.2 x | -18.6 x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Price to Book | 19.8 x | -40.4 x |
| Nbr of stocks (in thousands) | 41,930 | 58,101 |
| Reference price 2 | 0.0711 | 0.0560 |
| Announcement Date | 12/22/22 | 12/22/22 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 |
|---|---|---|
| Net sales 1 | 0.1672 | 0.1196 |
| EBITDA 1 | -0.056 | -0.1796 |
| EBIT 1 | -0.076 | -0.1996 |
| Operating Margin | -45.45% | -166.91% |
| Earnings before Tax (EBT) 1 | -0.0797 | -0.2898 |
| Net income 1 | -0.0791 | -0.2888 |
| Net margin | -47.33% | -241.51% |
| EPS 2 | -0.001363 | -0.004970 |
| Free Cash Flow | - | - |
| FCF margin | - | - |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 12/22/22 | 12/22/22 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 |
|---|---|---|
| Net Debt 1 | - | 0.08 |
| Net Cash position 1 | 0.17 | - |
| Leverage (Debt/EBITDA) | - | -0.445 x |
| Free Cash Flow | - | - |
| ROE (net income / shareholders' equity) | - | -164% |
| ROA (Net income/ Total Assets) | - | -35.6% |
| Assets 1 | - | 0.8107 |
| Book Value Per Share 2 | 0 | -0 |
| Cash Flow per Share 2 | 0 | 0 |
| Capex | - | - |
| Capex / Sales | - | - |
| Announcement Date | 12/22/22 | 12/22/22 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- EMGE Stock
- Financials Emergent Health Corp
